Yun Yen, M.D., Ph.D., currently co-leads the Developmental Cancer Therapeutics Program of the City of Hope Comprehensive Cancer Center.
Dr. Yen received his medical degree from Taipei Medical College in Taiwan and his PhD in Pathology and Cell Biology from Thomas Jefferson University, Philadelphia, Pennsylvania. Following residency training at St. Luke's Hospital, Temple University, Dr. Yen completed a fellowship in the Department of Internal Medicine, Hematology and Bone Marrow Transplantation and Oncology Section at Yale University School of Medicine. Subsequently, he joined City of Hope in 1993 as a staff physician. He is currently a professor in Medical Oncology and the Graduate School of Biological Sciences, as well as chief of Biochemical Pharmacology in the Department of Medical Oncology & Therapeutics Research.
Among Dr. Yen’s grant awards are several from the National Institutes of Health, including a prestigious predoctoral fellowship training grant while at Thomas Jefferson University and a K12 training grant while at City of Hope. In addition, he has been awarded U. S. Army Breast Cancer and Prostate Cancer grants, and the National Cancer Institute’s Cancer Therapy Evaluation Program has designated his laboratory the ribonucleotide reductase Real-Time PCR Reference Laboratory.
Dr. Yen holds membership in numerous professional organizations, including the American Association for the Advancement of Science, American Society of Clinical Oncology, Sigma-Xi Scientific Association, and Academy of Science New York. He has published more than 140 abstracts and peer-reviewed journal articles, and he serves as an ad hoc reviewer/referee for several journals and on the editorial board of the Journal of Clinical Colorectal Cancer.
As a highly experienced clinician, clinical investigator and basic scientist, Dr. Yen’s research interests focus on several markers of hepatocellular cancer, as well as investigational therapies for advanced malignancy.